Positive donor/recipient CMV status is not a detrimental factor for renal allograft/patient survival.
Krishnan
G
G
Our Lady of Lourdes Medical Center, Camden, New Jersey 08103.
Vaughn
W K
WK
Capelli
J P
JP
Glass
N R
NR
D000704:Analysis of Variance; D002102:Cadaver; D003586:Cytomegalovirus Infections / Q000453:epidemiology / Q000503:physiopathology*; D016206:Databases, Bibliographic; D005500:Follow-Up Studies; D015234:HLA-A Antigens / Q000276:immunology; D015235:HLA-B Antigens / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D015994:Incidence; D016030:Kidney Transplantation / Q000502:physiology*; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D013997:Time Factors; D014019:Tissue Donors; D014184:Transplantation, Homologous
D015234:HLA-A Antigens; D015235:HLA-B Antigens; D006684:HLA-DR Antigens